Omeros reported $625K in Ordinary Share Capital for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Acelrx Pharmaceuticals ACRX:US $ 0.12M 0M
Adamas Pharmaceuticals ADMS:US 50K 0
Adma Biologics ADMA:US $ 0.01M 0M
Aerie Pharmaceuticals AERI:US $ 0.05M 0M
Alexion Pharmaceuticals ALXN:US $ 0M 0M
Alnylam Pharmaceuticals ALNY:US $ 1.2M 0.01M
Biomarin Pharmaceutical BMRN:US $ 0.18M 0M
Cytokinetics CYTK:US $ 0.08M 0.01M
Dynavax Technologies DVAX:US $ 0.12M 0.01M
Heron Therapeutics HRTX:US $ 1.02M 0M
Insmed INSM:US $ 1.18M 32K
Knight Therapeutics Inc GUD:CN C$ 652.68M 15.74M
Macrogenics MGNX:US $ 0.61M 0.01M
Mirati Therapeutics MRTX:US $ 0.05M 0M
Omeros OMER:US $ 625K 1000
Pacira Pharmaceuticals PCRX:US $ 0.04M 0M
Sangamo Biosciences SGMO:US $ 1.46M 0M
Sarepta Therapeutics SRPT:US $ 0.01M 0M
United Therapeutics UTHR:US $ 0.7M 0M
Vertex Pharmaceuticals VRTX:US $ 2.56M 0.03M
Vital Therapies VTL:US $ 0M 0M
Xoma XOMA:US $ 85K 0